Last updated 2026-07-20
- Raised $2.5M Undisclosed Round, Jan 2010
Total raised
$2.5M
Last: Undisclosed Round 2010-01
Stage
Seed
Founded
2007
Headcount
3
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
About
AVA Bio Defender is a biotech company focused on creating genetic protection solutions to combat viruses and their mutations. They develop advanced molecular technologies such as siRNA, CRISPR, and lipid nano-particles to create treatments and resistant organisms for both poultry and humans. Their mission is to provide effective solutions against viral mutations, including future variants, with the potential to generate multi-billion dollar income in meat production and pharmaceuticals.
Funding history · 1 round · $2.5M total
2010-01
Undisclosed Round
$2.5M
Headcount over time
From 2 (2018-11) to 3 (2025-10) · +1 (+50%) · 4 points · source: Finder history + radar grounding
Q&A
- What is AVA Bio Defender's primary focus?
- AVA Bio Defender is a biotechnology company that specializes in developing mutation-resistant viral defense technologies, including heritable genetic resistance in animals and drug design for human therapy.
- What technologies does AVA Bio Defender utilize for viral defense?
- The company uses siRNA technology to develop a gene-delivery system for antiviral protection in animal cells, specifically for poultry. They also employ CRISPR technology for directed genome editing in animals.
- How does AVA Bio Defender address human viral infections?
- For humans, AVA Bio Defender develops molecules intended for use as medicine to treat infected individuals, designed to be effective regardless of viral mutations.
- When was AVA Bio Defender founded?
- AVA Bio Defender was founded in January 2007.
- What is the current employee count for AVA Bio Defender?
- AVA Bio Defender has 1-10 employees.
- What is AVA Bio Defender's total funding to date?
- AVA Bio Defender has raised a total of $2,500,000.
- When was AVA Bio Defender's last funding round?
- AVA Bio Defender's last funding round occurred in January 2010, raising $2,500,000.
- What is AVA Bio Defender's current product stage?
- AVA Bio Defender's product is currently in the clinical trial stage.
- In which sector does AVA Bio Defender primarily operate?
- AVA Bio Defender's primary sector is Health Tech & Life Sciences.
Team · 1
Lior Ziegler
Founder · Founder and CEO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentDrug Delivery
Technologies
BiologicalsGenesMolecules
Target customers
Agriculture & FoodLivestockPoultryHealthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
pharmaceuticalsbiotechnologyanimal-healthpoultrybiopharmaceuticaldrug-delivery
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | ava-biod.com/cgi-sys/suspendedpage.cgi |
|---|---|
| linkedin.com/company/66267434 |
Identifiers & details
| Legal name | AVA BIO-DEFENDER LTD |
|---|---|
| Founded | 2007-1 |
| Employees (exact) | 3 |
Radar intelligence
Web history (Wayback)
| Domain | ava-biod.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 513934323 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2007-01-30 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2023 |
| Active charges / liens | 0 |
| Registry events | 1 — violation (1) |
| Registered address | הלל 4 ירושלים |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-25 | עדכון הפרה |